KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Revenue (2016 - 2025)

Historic Revenue for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Cme's Revenue fell 295.38% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 584.21%. This contributed to the annual value of $6.1 billion for FY2024, which is 988.01% up from last year.
  • As of Q3 2025, Cme's Revenue stood at $1.5 billion, which was down 295.38% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Revenue registered a high of $1.7 billion during Q2 2025, and its lowest value of $1.1 billion during Q3 2021.
  • Over the past 5 years, Cme's median Revenue value was $1.4 billion (recorded in 2023), while the average stood at $1.4 billion.
  • In the last 5 years, Cme's Revenue plummeted by 1765.98% in 2021 and then soared by 1916.71% in 2023.
  • Over the past 5 years, Cme's Revenue (Quarter) stood at $1.1 billion in 2021, then increased by 5.27% to $1.2 billion in 2022, then grew by 19.17% to $1.4 billion in 2023, then rose by 5.98% to $1.5 billion in 2024, then rose by 0.81% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.6 billion during Q1 2025.